Results 121 to 130 of about 14,543 (225)
Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia
Multiplex plasma profiling of 124 CNS‐related proteins in genetic frontotemporal dementia (FTD) identified NfL and NfH as the most consistently altered biomarkers in both GRN‐ and C9orf72‐associated disease. Distinct protein changes emerged across genotypes, including changes in GFAP and VCAM1 in GRN‐FTD, and reduced NPTXR as well as nominally altered ...
Joel Simrén +11 more
wiley +1 more source
Amyotrophic lateral sclerosis (ALS) involves widespread cortical pathology beyond the motor cortex. Human‐induced pluripotent stem cell‐derived neural organoids model cortical tissue in vitro and provide a physiologically relevant platform to study disease mechanisms in ALS.
Kristel N. Eigenhuis +2 more
wiley +1 more source
Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog
A hexanucleotide repeat expansion in the C9orf72 gene is the most common cause of inherited forms of the neurodegenerative disease amyotrophic lateral sclerosis (ALS).
Abraham J. Langseth +7 more
doaj +1 more source
To investigate the involvement of C9orf72 in asthenozoospermia and its effects on spermatogonial energy metabolism and mitophagy.
Lu Hui +6 more
doaj +1 more source
C9orf72 dipeptides activate the NLRP3 inflammasome
Abstract Frontotemporal dementia and amyotrophic lateral sclerosis are neurodegenerative diseases with considerable clinical, genetic and pathological overlap. The most common cause of both diseases is a hexanucleotide repeat expansion in C9orf72.
Jack Rivers-Auty +6 more
openaire +3 more sources
Caractérisation d'un modèle murin knock out pour le gène C9orf72 [PDF]
An expansion of G4C2 repeats in C9ORF72 gene is the most common genetic cause of amyotrophic lateral sclerosis (ALS). These repeats lead to DNA epigenetic changes resulting in a decrease expression of C9ORF72.
Corbier, Camille
core
Targeting Gene C9orf72 Pathogenesis for Amyotrophic Lateral Sclerosis [PDF]
Amyotrophic lateral sclerosis (ALS) is a fatal adult neurodegenerative disorder. Since no cure has been found, finding effective therapeutic targets for ALS remains a major challenge.
Zhao Zhong Chong, Nizar Souayah
core +1 more source
Characterization of a C9orf72 knock out mouse model [PDF]
Une expansion de répétitions G4C2 dans le gène C9ORF72 est la cause génétique la plus commune de la sclérose latérale amyotrophique (SLA). Afin d’étudier les conséquences de la perte d’expression de C9ORF72, nous avons généré un modèle murin knockout ...
Corbier, Camille
core
Design considerations for C9orf72 disease prevention trials [PDF]
The idea that it might be possible to prevent some forms of amyotrophic lateral sclerosis and frontotemporal dementia has finally come of age. The hexanucleotide repeat expansion in the C9orf72 gene accounts for ∼10% of all amyotrophic lateral sclerosis ...
Gendron, Tania +23 more
core +2 more sources
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy [PDF]
Microsatellite repeat expansion disease loci can exhibit pleiotropic clinical and biological effects depending on repeat length. Large expansions in C9orf72 (100s-1000s of units) are the most common genetic cause of amyotrophic lateral sclerosis (ALS ...
Dickson DW +25 more
core

